A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AUR SEC filings page.
Aurora Innovation Inc (AUR) reported $3.0M in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Development-stage economics dominate: R&D spending and recurring cash outflows remain far ahead of the reported revenue base.
FY2025 pairs$745M of R&D spending with only$3M of revenue, showing that the organization is funding capability well before commercial scale is visible. Operating cash flow was-$581M against a-$816M net loss, so earnings and cash consumption point in the same direction, but the gap means noncash and working-capital effects materially shape the reported loss.
Operating cash flow stayed between
At FY2025, a current ratio of 11.9x and debt-to-equity of 0.1x indicate a balance sheet funded much more by equity than near-term borrowing. Reported liquidity equaled 30.1 months of the latest annual operating outflow, a substantial funding buffer relative to that measured outflow, although it is a balance-sheet comparison rather than a forecast.
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Aurora Innovation Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Aurora Innovation Inc held $1.5B in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $581.0M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Aurora Innovation Inc scores 56/100 among other emerging companies.
Aurora Innovation Inc had 1.94B shares outstanding at the end of fiscal year 2025, against 1.73B in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Aurora Innovation Inc scores 43/100 among other emerging companies.
Aurora Innovation Inc spent $745.0M on research and development in fiscal year 2025, which was 82.4% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Aurora Innovation Inc scores 99/100 among other emerging companies.
Not available for Aurora Innovation Inc, and counted as zero in the overall score.
Aurora Innovation Inc's operations used $581.0M of cash in fiscal year 2025, against $611.0M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Aurora Innovation Inc scores 47/100 among other emerging companies.
Aurora Innovation Inc's cash, cash equivalents and investments came to $1.5B at the end of fiscal year 2025, against $203.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Aurora Innovation Inc scores 93/100 among other emerging companies.
Aurora Innovation Inc scores 33.75, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($12.7B) relative to total liabilities ($203.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Aurora Innovation Inc passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Aurora Innovation Inc reported a net loss of $816.0M while operations used $581.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Aurora Innovation Inc generated $2.0M in revenue in Q2 2026. This represents an increase of 100.0% from the same quarter a year earlier. Against the prior quarter it is up 100.0%.
Aurora Innovation Inc's EBITDA was -$260.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 15.6% from the same quarter a year earlier. Against the prior quarter it is down 9.2%.
Aurora Innovation Inc reported -$270.0M in net income in Q2 2026. This represents a decrease of 34.3% from the same quarter a year earlier. Against the prior quarter it is down 21.1%.
Aurora Innovation Inc earned -$0.14 per diluted share (EPS) in Q2 2026. This represents a decrease of 27.3% from the same quarter a year earlier. Against the prior quarter it is down 27.3%.
Cash & Balance Sheet
Aurora Innovation Inc recorded an outflow of $256.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 69.5% from the same quarter a year earlier. Against the prior quarter it is down 39.1%.
Aurora Innovation Inc held $136.0M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Aurora Innovation Inc's ROE was -13.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.5 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Aurora Innovation Inc invested $211.0M in research and development in Q2 2026. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.
Aurora Innovation Inc invested $31.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 342.9% from the same quarter a year earlier. Against the prior quarter it is up 24.0%.
Not reported for Q2 2026.
AUR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M+100.0% | $1.0M | N/A | $1.0M | $1.0M | $0 | N/A | $0 |
| Cost of Revenue | $7.0M+40.0% | $6.0M | N/A | $6.0M | $5.0M | $0 | N/A | $0 |
| Gross Profit | -$5.0M-25.0% | -$5.0M | N/A | -$5.0M | -$4.0M | $0 | N/A | $0 |
| R&D Expenses | $211.0M+11.1% | $195.0M+7.1% | N/A | $179.0M+5.9% | $190.0M+11.8% | $182.0M+9.6% | N/A | $169.0M-7.1% |
| SG&A Expenses | $50.0M+38.9% | $44.0M+51.7% | N/A | $38.0M+40.7% | $36.0M+28.6% | $29.0M+7.4% | N/A | $27.0M-10.0% |
| Operating Income | -$266.0M-15.7% | -$244.0M-15.6% | N/A | -$222.0M-13.3% | -$230.0M-16.2% | -$211.0M-9.3% | N/A | -$196.0M+7.5% |
| EBITDA | -$260.0M-15.6% | -$238.0M-16.1% | N/A | -$216.0M-12.5% | -$225.0M-17.2% | -$205.0M-9.0% | N/A | -$192.0M+7.2% |
| Income Tax | $0 | $0 | N/A | $0 | $0 | $0 | N/A | $0 |
| Net Income | -$270.0M-34.3% | -$223.0M-7.2% | N/A | -$201.0M+3.4% | -$201.0M-10.4% | -$208.0M-26.1% | N/A | -$208.0M-9.5% |
| EPS (Basic) | -$0.14-27.3% | -$0.11+8.3% | -$0.10+9.1% | -$0.11+15.4% | -$0.11+8.3% | -$0.12-9.1% | -$0.11+8.3% | -$0.130.0% |
| EPS (Diluted) | -$0.14-27.3% | -$0.11+8.3% | -$0.10+9.1% | -$0.11+15.4% | -$0.11+8.3% | -$0.12-9.1% | -$0.11+8.3% | -$0.130.0% |
| Diluted Shares (Avg) | 1.98B+10.7% | 1.95B+11.7% | N/A | 1.89B+14.1% | 1.78B+14.9% | 1.74B+13.5% | N/A | 1.66B+15.7% |
Not reported in any period shown, so not listed: Interest Expense.
AUR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.2B-2.1% | $2.2B+5.5% | $2.3B+9.6% | $2.5B+10.8% | $2.2B+15.7% | $2.1B-0.9% | $2.1B-4.3% | $2.3B-3.8% |
| Current Assets | $1.3B-6.6% | $1.3B+6.6% | $1.3B+5.0% | $1.3B+0.7% | $1.3B+28.5% | $1.2B+4.5% | $1.3B+3.0% | $1.3B-14.0% |
| Cash & Equivalents | $136.0M-34.0% | $273.0M+60.6% | $221.0M+4.7% | $87.0M-66.9% | $206.0M-48.8% | $170.0M-62.6% | $211.0M-57.9% | $263.0M-72.4% |
| Short-Term Investments | $1.1B-2.0% | $952.0M-3.7% | $1.1B+4.2% | $1.2B+17.8% | $1.1B+78.5% | $989.0M+49.4% | $1.0B+44.8% | $985.0M+90.2% |
| Long-Term Investments | $0 | $52.0M | $183.0M | $357.0M+243.3% | $0 | $0-100.0% | $0-100.0% | $104.0M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | $0 | N/A |
| Total Liabilities | $214.0M-4.0% | $221.0M-22.7% | $203.0M-22.8% | $219.0M-11.3% | $223.0M+13.2% | $286.0M+23.8% | $263.0M+5.2% | $247.0M+12.3% |
| Current Liabilities | $110.0M+39.2% | $134.0M+7.2% | $111.0M+5.7% | $84.0M-9.7% | $79.0M-2.5% | $125.0M+13.6% | $105.0M-5.4% | $93.0M+2.2% |
| Non-Current Liabilities | $104.0M-27.8% | $87.0M-46.0% | $92.0M-41.8% | $135.0M-12.3% | $144.0M+24.1% | $161.0M+33.1% | $158.0M+13.7% | $154.0M+19.4% |
| Total Equity | $2.0B-1.9% | $2.0B+10.0% | $2.1B+14.1% | $2.3B+13.5% | $2.0B+16.0% | $1.8B-3.9% | $1.9B-5.5% | $2.0B-5.4% |
| Retained Earnings | -$5.7B-18.9% | -$5.4B-18.2% | -$5.2B-18.7% | -$5.0B-19.3% | -$4.8B-20.5% | -$4.6B-21.0% | -$4.4B-20.7% | -$4.2B-21.9% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Long-Term Debt.
AUR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$225.0M-56.3% | -$159.0M-12.0% | -$146.0M-2.8% | -$149.0M-4.2% | -$144.0M+18.2% | -$142.0M+5.3% | -$142.0M-6.8% | -$143.0M+2.7% |
| Depreciation & Amortization | $6.0M+20.0% | $6.0M0.0% | $13.0M+116.7% | $6.0M+50.0% | $5.0M-16.7% | $6.0M+20.0% | $6.0M0.0% | $4.0M-20.0% |
| Stock-Based Compensation | $60.0M+9.1% | $46.0M+35.3% | N/A | $51.0M+45.7% | $55.0M+44.7% | $34.0M-5.6% | N/A | $35.0M-14.6% |
| Capital Expenditures | $31.0M+342.9% | $25.0M+212.5% | $8.0M0.0% | $8.0M+14.3% | $7.0M-36.4% | $8.0M0.0% | $8.0M+100.0% | $7.0M+40.0% |
| Free Cash Flow | -$256.0M-69.5% | -$184.0M-22.7% | -$154.0M-2.7% | -$157.0M-4.7% | -$151.0M+19.3% | -$150.0M+5.1% | -$150.0M-9.5% | -$150.0M+1.3% |
| Investing Cash Flow | -$109.0M+7.6% | $209.0M+1000.0% | $273.0M+274.0% | -$419.0M+10.1% | -$118.0M-198.3% | $19.0M-81.2% | $73.0M+122.5% | -$466.0M-548.1% |
| Financing Cash Flow | $199.0M-33.2% | $4.0M-95.1% | $6.0M-64.7% | $448.0M-4.5% | $298.0M+7350.0% | $82.0M+4000.0% | $17.0M+325.0% | $469.0M-43.6% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AUR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -250.0% | -500.0% | N/A | -500.0% | -400.0% | N/A | N/A | N/A |
| Operating Margin | -13300.0% | -24400.0% | N/A | -22200.0% | -23000.0% | N/A | N/A | N/A |
| Net Margin | -13500.0% | -22300.0% | N/A | -20100.0% | -20100.0% | N/A | N/A | N/A |
| Return on Equity | -13.8%-3.7pp | -11.3%+0.3pp | N/A | -8.8%+1.5pp | -10.1%+0.5pp | -11.7%-2.8pp | N/A | -10.3%-1.4pp |
| Return on Assets | -12.5%-3.4pp | -10.2%-0.2pp | N/A | -8.0%+1.2pp | -9.1%+0.4pp | -10.0%-2.1pp | N/A | -9.2%-1.1pp |
| Current Ratio | 11.38-5.6x | 9.49-0.1x | 11.86-0.1x | 15.29+1.6x | 16.96+4.1x | 9.54-0.8x | 11.94+1.0x | 13.71-2.6x |
| Debt-to-Equity | 0.110.0x | 0.110.0x | 0.090.0x | 0.100.0x | 0.110.0x | 0.160.0x | 0.140.0x | 0.120.0x |
| Asset Turnover | 0.000.0x | 0.000.0x | N/A | 0.000.0x | 0.000.0x | 0.00 | N/A | 0.00 |
| FCF Margin | -12800.0% | -18400.0% | N/A | -15700.0% | -15100.0% | N/A | N/A | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Aurora Innovation Inc AUR | FY2025 | $3.0M | -$816.0M | N/A | $12.7B | 56/100 |
| Jack Henry & Associates JKHY | FY2026 | $2.5B | $502.8M | 19.8% | $11.1B | 74/100 |
| Caci Intl Inc CACI | FY2026 | $9.6B | $535.8M | 5.6% | $13.4B | 54/100 |
| Gartner Inc IT | FY2025 | $6.5B | $729.0M | 11.2% | $10.7B | 49/100 |
| CDW Corp CDW | FY2025 | $22.4B | $1.1B | 4.8% | $17.8B | 51/100 |
| Leidos Holdings LDOS | FY2025 | $17.2B | $1.4B | 8.4% | $16.1B | 58/100 |
Where Aurora Innovation Inc Ranks
Frequently Asked Questions
What is Aurora Innovation Inc's annual revenue?
Aurora Innovation Inc (AUR) reported $3.0M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Aurora Innovation Inc profitable?
No, Aurora Innovation Inc (AUR) reported a net income of -$816.0M in fiscal year 2025.
What is Aurora Innovation Inc's EBITDA?
Aurora Innovation Inc (AUR) had EBITDA of -$871.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Aurora Innovation Inc's return on equity (ROE)?
Aurora Innovation Inc (AUR) has a return on equity of -38.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Aurora Innovation Inc's free cash flow?
Aurora Innovation Inc (AUR) recorded an outflow of $612.0M in free cash flow during fiscal year 2025. This represents a 5.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Aurora Innovation Inc's operating cash flow?
Aurora Innovation Inc (AUR) recorded an outflow of $581.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Aurora Innovation Inc's total assets?
Aurora Innovation Inc (AUR) had $2.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Aurora Innovation Inc's capital expenditures?
Aurora Innovation Inc (AUR) invested $31.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Aurora Innovation Inc spend on research and development?
Aurora Innovation Inc (AUR) invested $745.0M in research and development during fiscal year 2025.
What is Aurora Innovation Inc's current ratio?
Aurora Innovation Inc (AUR) had a current ratio of 11.86 as of fiscal year 2025, which is generally considered healthy.
What is Aurora Innovation Inc's debt-to-equity ratio?
Aurora Innovation Inc (AUR) had a debt-to-equity ratio of 0.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Aurora Innovation Inc's return on assets (ROA)?
Aurora Innovation Inc (AUR) had a return on assets of -34.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Aurora Innovation Inc's P/E ratio?
Aurora Innovation Inc (AUR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $12.7B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Aurora Innovation Inc's price-to-sales ratio?
Aurora Innovation Inc (AUR) has no price-to-sales ratio at the moment: outside the range published as a multiple (on $3.0M revenue, FY2025). The market capitalization is $12.7B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Aurora Innovation Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Aurora Innovation Inc (AUR) held $1.5B in cash, cash equivalents and investments, and reported an operating cash outflow of $581.0M over that year. Dividing the one by the other, the reported balance equals about 30 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Aurora Innovation Inc's Altman Z-Score?
Aurora Innovation Inc (AUR) has an Altman Z-Score of 33.75, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Aurora Innovation Inc's Piotroski F-Score?
Aurora Innovation Inc (AUR) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aurora Innovation Inc's earnings high quality?
Aurora Innovation Inc (AUR) reported a net loss of $816.0M while operations used $581.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Aurora Innovation Inc?
Aurora Innovation Inc (AUR) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.